← News
Stocks· August 03, 2026 at 08:12 AM
Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
This billionaire investor is betting big on a revolutionary approach in treating pancreatic cancer.
Affected symbols
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
StocksMedium impactNeutral3h
Semiconductor Stocks Are Down 22%. Here's the 1 Chip Stock I'd Buy Right Now.
via Yahoo Finance
NVDA
StocksMedium impactNeutral3h
AMZN Stock Rises Premarket: Wall Street Sees Bigger AI Returns Ahead As Amazon Cloud Momentum Builds
via Yahoo Finance
AMZN
MacroMedium impactNeutral3h
The Federal Reserve Just Did Something That No One's Witnessed in 56 Years -- and It Has Significant Implications for the Stock Market
via Yahoo Finance
NVDA
StocksMedium impactNeutral3h
Up Just 2% and Still Dominant: Is Amazon the 1 Growth Stock Worth Buying Right Now?
via Yahoo Finance
NVDA